Biohaven Brings Clifford Bechtold Aboard as Chief Operating Officer

Biohaven (NYSE: [[ticker:BHVN]]) has appointed Clifford Bechtold to serve as chief operating officer of the New Haven, CT, company. Bechtold most recently worked at Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) as development team leader for genetically defined diseases. His work there encompassed programs in neuromuscular and neurodegenerative diseases. Biohaven is developing treatments for neurological diseases.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.